Skip to content

Trephine Osteotomy in Lateral Sinus Lift

Lateral Sinus Lift Technique Using Trephine Osteotomy With Simultaneous Implant Placement (Clinical Trial)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04625192
Enrollment
14
Registered
2020-11-12
Start date
2020-02-01
Completion date
2021-01-30
Last updated
2020-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sinus Lift

Brief summary

Trephine osteotomy was used for lateral sinus lifting technique associated with sinus floor augmentation using the autogenous bone resulting from implant drilling using specialized trephine drills.

Detailed description

The study includes 14 patients in whom the lateral sinus lift technique was performed using the trephine osteotomy with simultaneous implant placement. Sinus floor augmentation with autogenous bone graft resulting from implant site preparation with trephine drills. Implant stability and rate of complications such as Schneiderian membrane perforation and bleeding will be assessed. Patients will also provide their subjective assessment of postoperative pain and swelling. Vertical bone height, that will be gained, will be assessed radiographically

Interventions

PROCEDURETrephine osteotomy

* Using a trephine on a straight implant handpiece (at approximately 1800 rpm) with copious irrigation to avoid overheating the bone, a round bone cut will be made 4 -5 mm above the crest of the alveolar ridge. * The trephine is positioned perpendicular to the lateral wall, removing the outer cortex with a very gentle touch to avoid tearing the schneiderian membrane.

Sponsors

Hams Hamed Abdelrahman
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Patients of both genders requiring implant placement in the posterior maxilla. * Age between 20-50 years. * Tooth extractions at the implant sites were performed at least 4 months before surgery. * Residual bone height between the alveolar bone crest and the sinus floor ranges from 4 to 6 mm. * Patients who are willing and fully capable to comply with the study protocol

Exclusion criteria

* Maxillary sinus pathologies (sinusitis, long standing nasal obstruction) * Any disease contraindicating surgery (e.g. uncontrolled diabetes) * Heavy smokers * Acute oral infections * Poor oral hygiene * A history of radiotherapy or chemotherapy of the head and neck region

Design outcomes

Primary

MeasureTime frameDescription
Change in Implant stabilityat baseline and 6 monthsThis will be measured by implant stability meter (OsstellTM)
change in bone densityat baseline, 3rd and 6th monthsPanoramic radiography will be performed immediately postoperatively and cone beam computed tomography (CBCT)
change in bone volumeat baseline, 3rd and 6th monthsPanoramic radiography will be performed immediately postoperatively and cone beam computed tomography (CBCT)
change in bone vertical bone heightat baseline, 3rd and 6th monthsPanoramic radiography will be performed immediately postoperatively and cone beam computed tomography (CBCT)

Secondary

MeasureTime frameDescription
post operative painafter 1 weekThis will be assessed using a 10-point Visual Analogue Scale (VAS) in the 1st week postoperatively. (0-1=None, 2-4=Mild-Moderate, 8-10= Severe)
Postoperative edemaafter 1 week* None (no inflammation). * Mild (intraoral swelling confined to the surgical field). * Moderate (extraoral swelling in the surgical zone). * Severe (extraoral swelling spreading beyond the surgical zone

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026